Study design
seizure
SECONDARY
This prospective randomized study was conducted to evaluate the efficacy, safety, and tolerability of the KD and its effect on EEG features among children with DRE.Our primary outcome was to assess the clinical effectiveness of KD (classic KD and MAD) regarding onset of seizure control, seizure frequency and seizure severity, and to assess long-term safety of KD regarding AE and the effect of KD on growth and lipid profile (cardiovascular risk). The secondary outcome was the evaluation of the effect of KD on EEG features prior to and 3 and 6 months after the KD treatment with the possibility of withdrawal of ASM.